and in the remainder information was obtained by a standard questionnaire. Results -There were 106 positive results, 45 (44%) from patients with Wegener's granulomatosis. The sensitivity and specificity of a positive ANCA test result in this study were 65% and 77% respectively. For a diagnosis of Wegener's granulomatosis the sensitivity and positive predictive accuracy of a positive cytoplasmic ANCA (c-ANCA) test were greater than of a positive perinuclear ANCA (p-ANCA) test. There were 61 positive tests in 266 patients who did not have Wegener's granulomatosis (23%); of these 27 were from patients with infection, 10 with fibrotic lung disease, nine with underlying connective tissue disease, seven with malignancy, and five following pulmonary emboli. Most of these positive ANCA results were p-ANCA (69%) rather than c-ANCA (31%). Serial ANCA requests were made in 15 cases of patients without Wegener's granulomatosis who had an initial positive ANCA test result. In all cases the ANCA tests subsequently became negative. Conclusions -In this study the sensitivity and specificity of a positive ANCA test result were less than that reported from specialised centres. However, the test was found to be useful in clinical practice, especially c-ANCA, in conjunction with clinical symptoms of respiratory pathology and evidence of renal disease. (Thorax 1994; 49:213-217) The first clinical report of Wegener Definition of c-ANCA and p-ANCA Sera were recorded as c-ANCA positive if cytoplasmic staining was in a granular pattern with central accentuation, and p-ANCA positive if staining was perinuclear on ethanol fixed slides and cytoplasmic on formaldehyde/acetone fixed slides. Positive sera were retested at serial twofold dilutions to a titre of 1/320.
Positive nuclear and perinuclear sera were also tested for other autoantibodies by immunofluorescence against a composite block of rat liver, kidney, stomach, and oesophagus at a 1/10 dilution. Positive antinuclear antibodies were titrated. Rheumatoid factor was detected by latex or the Rose Waaler test, or both.
Negative control sera were obtained from healthy AB blood donors and positive controls from patients with biopsy proven Wegener's granulomatosis.
Quality control
The regional reference laboratory belongs to the UK external quality assurance scheme for ANCA. Analysis of internal quality control samples showed that positive results did not vary by more than one dilution. In our laboratory between batch coefficients of variation for c-ANCA and p-ANCA were 4-5% and 6-6% respectively.
STATISTICAL ANALYSIS
The X2 test with Yates' correction, if appropriate, was used to analyse the data. Statistical significance was taken at or below the 5% level.
Specificity is a measure of the incidence of negative results in subjects known to be free of the disease and sensitivity a measure of the incidence of positive results in subjects known to have the disease. However, a highly specific and sensitive test may still detect a significant number of "false positives," especially if the condition has a low prevalence.'7 More useful is the concept of positive predictive value, which is the percentage of positive tests which are "true positives."' '7 Results Clinical data were obtained from all 335 patients with respiratory tract symptoms for whom an ANCA test was requested in 1990. The majority of requests were made by respiratory physicians (168 (50%)), followed by nephrologists (79 (24%)), general physicians (63 (19%)), otolaryngologists/ophthalmic surgeons (19 (6%)), and pathologists (six (2%)). There were 106 positive ANCA results, 54 c-ANCA and 52 p-ANCA.
The case notes and necropsy reports were reviewed in 231 cases (69%), including all those patients with a positive ANCA result. In the remaining cases information was obtained by the standard questionnaire and confirmed where necessary by the attending physician.
The median duration of follow up in the surviving patients with positive ANCA results was 31 months (range 25-38), and no patient with an initial positive ANCA result but with no supporting evidence of Wegener's granulomatosis has gone on to develop the disease. WEGENER Table 3 sets out symptoms and investigations at presentation in those patients without Wegener's granulomatosis who had positive ANCA results and those who did not. Table 4 compares the symptoms and investigations in the patients with Wegener's granulomatosis with those 266 patients who had respiratory symptoms but did not have Wegener's granulomatosis. with Wegener's granulomatosis was less than that reported in earlier studies.57 Most are from specialist centres and are likely to be subject to selection bias. By including all referrals for an ANCA test from the south west of England, a population of some 3 4 million, we had hoped to avoid any selection bias that may have been present in previous series from highly specialised centres.
Other workers have suggested that the sensitivity and specificity of the test can be increased only by including those patients with clinically active disease.6 In this series there was no difference in terms of the number of patients with positive ANCA results or the ANCA titre between those with active disease and those in remission. It has been suggested that the specificity of the test can be improved by restricting analysis to patients in whom there is high clinicAl suspicion of Wegener's granulomatosis.'8 In our series restricting analysis to patients presenting with respiratory tract symptoms did not result in the sensitivity or specificity of previously published series.'920 From involvement in external quality assurance schemes we have no reason to believe that our assay performed less efficiently than that used in other laboratories.
In our series the sensitivity and positive predictive value for a c-ANCA result in a patient presenting with respiratory symptoms was much greater than that of a p-ANCA result. This supports some of the earlier studies.57
Sixty one patients presenting with respiratory symptoms had a positive ANCA test result compared with 45 patients with proven Wegener's granulomatosis. The eventual diagnosis in these patients fell into five major groups: pulmonary infection, most commonly bacterial and lower respiratory tract; fibrosing lung disease; connective tissue diseases associated with vasculitis; tumours; and pulmonary embolic disease. The clinical presentation and routine haematological, biochemical, immunological, and radiological investigations were similar in those patients without Wegener's granulomatosis who had both positive and negative ANCA results.
More of those patients with a positive ANCA result had increased serum IgG concentrations. One possible explanation for a positive ANCA result is non-specific IgG binding, and this has been suggested in previous studies which have reported positive results in patients with underlying infections.910 Some tumours such as lymphomas are known to affect the immune system and may affect immunoglobulin synthesis. However, we have not been able to show any relation between serum IgG concentration and ANCA titre. Positive results may be expected in Table 3 In most cases with initial "false positive" ANCA results serial determinations became negative with time, so repetition of the test may be more helpful than a single result. However, the ANCA test was found to be useful in helping to support the diagnosis of Wegener's granulomatosis, especially when of the c-ANCA pattern and in association with the combination of upper and lower respiratory tract symptomatology in a patient with abnormal urine stick testing and raised blood creatinine concentrations.
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